
Quarterly report 2025-Q3
added 11-14-2025
TELA Bio Market Cap 2011-2026 | TELA
As of February 25, 2026 TELA Bio has a market cap of $ 18.1 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap TELA Bio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131 M | 164 M | 177 M | 185 M | 26.1 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 185 M | 26.1 M | 137 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
2.07 B | $ 13.93 | 5.85 % | $ 2.09 B | ||
|
AxoGen
AXGN
|
1.5 B | $ 32.5 | -8.14 % | $ 1.5 B | ||
|
Bio-Rad Laboratories
BIO
|
7.81 B | $ 268.7 | 0.17 % | $ 7.58 B | ||
|
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Cognyte Software Ltd.
CGNT
|
661 M | $ 6.39 | 0.79 % | $ 459 M | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
Apyx Medical Corporation
APYX
|
45.7 M | $ 3.54 | -0.84 % | $ 123 M | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
466 M | $ 14.55 | -1.42 % | $ 393 M | ||
|
EDAP TMS S.A.
EDAP
|
60 M | $ 4.47 | -1.11 % | $ 167 M | ||
|
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
6.9 K | $ 39.77 | 0.53 % | $ 5.93 K | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
113 B | $ 75.15 | 1.05 % | $ 111 B | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
Electromed
ELMD
|
175 M | $ 23.15 | -5.16 % | $ 196 M | ||
|
CONMED Corporation
CNMD
|
1.32 B | $ 46.06 | 1.5 % | $ 1.43 B | ||
|
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
IRadimed Corporation
IRMD
|
670 M | $ 99.09 | -1.92 % | $ 1.26 B | ||
|
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | ||
|
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | ||
|
Delcath Systems
DCTH
|
375 M | $ 9.95 | 2.16 % | $ 284 M | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
LivaNova PLC
LIVN
|
2.28 B | $ 69.05 | 1.02 % | $ 3.75 B | ||
|
Eargo
EAR
|
17 M | - | - | $ 10.2 M | ||
|
InMode Ltd.
INMD
|
928 M | $ 13.98 | -1.55 % | $ 904 M | ||
|
Pulmonx Corporation
LUNG
|
341 M | $ 1.51 | 2.03 % | $ 59.1 M | ||
|
Establishment Labs Holdings
ESTA
|
1.2 B | $ 79.67 | 6.28 % | $ 2.24 B | ||
|
Myomo
MYO
|
5.64 M | $ 0.65 | -5.24 % | $ 4.58 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
258 M | $ 2.43 | 2.53 % | $ 143 M | ||
|
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | ||
|
Orthofix Medical
OFIX
|
491 M | $ 12.75 | -6.18 % | $ 505 M | ||
|
FONAR Corporation
FONR
|
85.2 M | $ 18.57 | -0.11 % | $ 122 M | ||
|
Insulet Corporation
PODD
|
18.1 B | $ 245.25 | -1.66 % | $ 17.3 B | ||
|
Globus Medical
GMED
|
12.5 B | $ 91.88 | -1.63 % | $ 12.4 B |